- Global Pharma News & Resources

Demand for Molecular Imaging Set for Stupendous Growth in and Post 2020, Buoyed by the Global COVID-19 Pandemic

In a recent publication titled “Molecular Imaging Market: Global Industry Analysis (2012 –2016) and Opportunity Assessment (2017 – 2027),” we have considered the weighted average pricing for different molecular imagingdevices. This has been done on the basis of information gathered from reliable secondarysources validated through marketplace discussions and private company databases. We have also observed that pricing values of molecular imaging devices have been counter validated with market experts through primary research along with regional variations in price levels. It is very necessary to note that this pricing analysis does not include margins analysis from the manufacturers end. Currency fluctuations have not been taken into account and the analysis is static in nature. It also rules out impact of extreme events in specific countries. Weighted averaging of high-end and low-end pricing has been done to rule out effect of extreme values and brand weightages. A demand-supply gap analysis has been performed involving both marketplace discussion and desk research to determine pricing premiums.

For More Insights Into The Market, Request a Sample of This Report@

Report Structure

This report begins with the market definition, followed by definitions of the different molecular imaging devices. The market dynamics section includes Future Market Insights’ analysis on key trends, drivers, restraints, opportunities and macro-economic factors that are influencing the growth of the global molecular imaging market and key regulations for medical devices. Also, the pricing analysis of different products in the segment is mentioned for upcoming molecular imaging products. The report analyses the market on the basis of application and presents forecast by value for the next 10 years. The global molecular imaging market segments such as modality type, application, end-user and region, have been analysed on Basis Point Share (BPS) to understand the individual segment’s respective contributions to market growth. This detailed level of information is important for identifying various key trends in the global molecular imaging market.

At the end of the report, list of key players have been provided who are engaged in the market for global molecular imaging. This section is preferably designed to provide clients with an aim and detailed comparative assessment of key providers specific to the market segment in the global molecular imaging market and the potential players. In addition, this section includes company details, company overview, key developments and market strategies of the profiled key player active in the global molecular imaging market. Detailed profiles of molecular imaging devices manufacturers are also included in the scope of the report to evaluate their strategies in a bid to sustain in this competitive market.

Global Molecular Imaging Market: Segmentation

Modality Type End User Application Region
MR Spectroscopy
Molecular Ultrasound Imaging
Software On Premise Solutions
Cloud Based Solutions
Hospitals 500+ Beds
200-499 Beds
Less than 200 Beds
Ambulatory Surgical Centers
Diagnostic Imaging Centers
Gastrointestinal Disorders
Neurology Disorders
North America
Western Europe
Eastern Europe
Latin America

Table Of Content

1. Executive Summary

1.1. Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Molecular Imaging Market View Point Analysis 

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Regional Pricing Analysis by Product Type

3.4. Installed Base Analysis

4. North America Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016

4.5.1. Positron Emission Tomography (PET)

4.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)

4.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

4.5.4. Single Photon Emission Computed Tomography (SPECT)

4.5.5. Magnetic Resonance Spectroscopy

4.5.6. Molecular Ultrasound Imaging

4.5.7. Software On Premises Solutions Cloud Based Solutions

4.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027

4.6.1. Positron Emission Tomography (PET)

4.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)

4.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

4.6.4. Single Photon Emission Computed Tomography (SPECT)

4.6.5. Magnetic Resonance Spectroscopy

4.6.6. Molecular Ultrasound Imaging

4.6.7. Software On Premises Solutions Cloud Based Solutions

4.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016

4.7.1. Hospitals 500+ Beds 200-499 Beds Less than 200 Beds

4.7.2. Ambulatory Surgical Centers

4.7.3. Diagnostic Imaging Centers

4.8. Market Size (US$ Mn) Forecast By Application, 2017–2027

4.8.1. Cardiology

4.8.2. Oncology

4.8.3. Gastrointestinal Disorders

4.8.4. Neurology Disorders

4.8.5. Others

4.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

4.9.1. Cardiology

4.9.2. Oncology

4.9.3. Gastrointestinal Disorders

4.9.4. Neurology Disorders

4.9.5. Others

4.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

4.10.1. Hospitals 500+ Beds 200-499 Beds Less than 200 Beds

4.10.2. Ambulatory Surgical Centers

4.10.3. Diagnostic Imaging Centers

4.11. Drivers and Restraints: Impact Analysis

4.12. Market Attractiveness Analysis

4.12.1. By Country

4.12.2. By Modality

4.12.3. By Application

4.12.4. By End User

4.13. Key Representative Market Participants

4.14. Market Presence (Intensity Map)

Request To Browse Full Table of Content, Figure And Tables @

Research Methodology

Macro-economic indicators such as molecular imaging market outlook, gross domestic product and others has been considered to arrive at the indicated market numbers. Bottom-up approach has been used to assess market numbers, while top-down approach has been used to counter-validate the reached numbers for molecular imaging Market numbers. The analysts of Future Market Insights have performed systematic exhaustive secondary research to analyse the required data points to arrive at the overall market numbers. Our analysts have developed questionnaires for each node in the value chain to extract the required market information through primary research interviews. While conducting interviews we have used distinguished essential resources. Data is validated by triangulation method, wherein secondary, primary and Future Market Insight’s analysis have contributed to the final data.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.


Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries:
For Media Enquiries:

Editor Details

Last Updated: 10-Dec-2020